[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1031691A1 - 2-phenyl-1-[-(2-aminoethoxy)-benzyl-indole in combination with estrogens - Google Patents

2-phenyl-1-[-(2-aminoethoxy)-benzyl-indole in combination with estrogens

Info

Publication number
HK1031691A1
HK1031691A1 HK01102189A HK01102189A HK1031691A1 HK 1031691 A1 HK1031691 A1 HK 1031691A1 HK 01102189 A HK01102189 A HK 01102189A HK 01102189 A HK01102189 A HK 01102189A HK 1031691 A1 HK1031691 A1 HK 1031691A1
Authority
HK
Hong Kong
Prior art keywords
aminoethoxy
estrogens
indole
benzyl
phenyl
Prior art date
Application number
HK01102189A
Inventor
James Harrison Pickar
Barry Samuel Komm
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22151320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1031691(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of HK1031691A1 publication Critical patent/HK1031691A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK01102189A 1998-05-15 2001-03-26 2-phenyl-1-[-(2-aminoethoxy)-benzyl-indole in combination with estrogens HK1031691A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7956198A 1998-05-15 1998-05-15
PCT/US1999/010217 WO1999059581A1 (en) 1998-05-15 1999-05-11 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens

Publications (1)

Publication Number Publication Date
HK1031691A1 true HK1031691A1 (en) 2001-06-22

Family

ID=22151320

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01102189A HK1031691A1 (en) 1998-05-15 2001-03-26 2-phenyl-1-[-(2-aminoethoxy)-benzyl-indole in combination with estrogens

Country Status (42)

Country Link
EP (1) EP1076558B1 (en)
JP (3) JP2002515431A (en)
KR (1) KR100620772B1 (en)
CN (1) CN1230163C (en)
AP (1) AP1424A (en)
AR (1) AR020074A1 (en)
AT (1) ATE245026T1 (en)
AU (1) AU760378B2 (en)
BE (1) BE2015C026I2 (en)
BG (1) BG64783B1 (en)
BR (1) BR9911040A (en)
CA (1) CA2329530A1 (en)
CU (1) CU23241B7 (en)
CY (1) CY2015020I1 (en)
CZ (1) CZ299334B6 (en)
DE (1) DE69909616T2 (en)
DK (1) DK1076558T3 (en)
EA (1) EA005932B1 (en)
EE (1) EE04262B1 (en)
ES (1) ES2203131T3 (en)
FR (1) FR15C0035I2 (en)
GE (1) GEP20033079B (en)
HK (1) HK1031691A1 (en)
HR (1) HRP20000778B1 (en)
HU (2) HU226587B1 (en)
ID (1) ID26890A (en)
IL (1) IL139130A (en)
IN (1) IN192220B (en)
LT (1) LTC1076558I2 (en)
LU (1) LU92699I2 (en)
NO (2) NO328129B1 (en)
NZ (1) NZ508200A (en)
OA (1) OA11552A (en)
PL (1) PL194750B1 (en)
PT (1) PT1076558E (en)
SI (1) SI1076558T1 (en)
SK (1) SK284666B6 (en)
TR (1) TR200003377T2 (en)
TW (1) TW565554B (en)
UA (1) UA66861C2 (en)
WO (1) WO1999059581A1 (en)
ZA (1) ZA200006959B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1076558T1 (en) * 1998-05-15 2003-10-31 Wyeth 2-phenyl-1-(-(2-aminoethoxy)-benzyl -indole in combination with estrogens
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
ATE447947T1 (en) 1999-07-06 2009-11-15 Endorech Inc PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INSULINRESIENCE
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
MXPA02012896A (en) * 2000-07-06 2003-10-24 Wyeth Corp Combinations of statins, estrogenic agents and optionally estrogens.
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
WO2002003992A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating prosthesis-related bone degeneration
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
AU2001273125A1 (en) * 2000-07-06 2002-01-21 American Home Products Corporation Combinations of bisphosphonates, estrogenic agents and optionally estrogens
DE10117441A1 (en) * 2001-04-03 2002-10-10 Schering Ag 1-indolyl derivatives, their use in the manufacture of medicaments, a process for the preparation of 1-indolyl derivatives and pharmaceutical preparations containing 1-indolyl derivatives
EP1411922A1 (en) 2001-07-31 2004-04-28 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
KR100470274B1 (en) 2002-11-08 2005-02-05 진 장 Method of phase transition of amorphous material using a cap layer
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
FR2880625B1 (en) * 2005-01-07 2007-03-09 Sanofi Aventis Sa N- (HETEROARYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
DK2276732T3 (en) 2008-04-16 2015-08-17 Karobio Ab Novel østrogenreceptorligander
AR072297A1 (en) * 2008-06-27 2010-08-18 Novartis Ag DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE.
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN102690225B (en) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 New synthetic method of bazedoxifene
CN103709090A (en) * 2014-01-16 2014-04-09 江苏万特制药有限公司 Preparation method of bazedoxifene acetate and key intermediate thereof
CN103739540B (en) * 2014-01-20 2016-05-04 华润赛科药业有限责任公司 A kind of preparation method of bazedoxifene acetate intermediate
CN105669518B (en) * 2014-12-04 2019-06-04 上海医药集团股份有限公司 The preparation method of bazedoxifene acetate and its A crystal form
JP7287964B2 (en) * 2017-12-15 2023-06-06 ブリストル-マイヤーズ スクイブ カンパニー substituted indole ether compounds
IT201800006562A1 (en) * 2018-06-21 2019-12-21 PROCEDURE AND USEFUL INTERMEDIATES FOR THE PREPARATION OF INDOLES
CN115380026B (en) * 2020-03-17 2023-11-07 南京明德新药研发有限公司 Protein degradation modulators and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
KR950701317A (en) * 1992-05-08 1995-03-23 오오쓰까 아끼히꼬 Indole Derivative
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
DE4426625A1 (en) * 1994-07-27 1996-03-14 Schering Ag 2-phenylindoles, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of medicaments
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
DE122009000061I1 (en) * 1996-04-19 2009-12-31 Wyeth N D Ges D Staates Delawa Estrogenic compounds
JP2000514074A (en) * 1996-07-09 2000-10-24 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ Indole derivatives for the treatment of osteoporosis
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
JP2001519410A (en) * 1997-10-15 2001-10-23 アメリカン・ホーム・プロダクツ・コーポレイション New aryloxy-alkyl-dialkylamines
EP1049472A4 (en) * 1997-10-28 2002-04-03 Merck & Co Inc Antagonists of gonadotropin releasing hormone
ID24568A (en) * 1997-11-06 2000-07-27 American Home Prod ORAL CONTRACEPTION THAT CONTAINS ANTI-ESTROGEN PLUS PROGESTIN
SI1076558T1 (en) * 1998-05-15 2003-10-31 Wyeth 2-phenyl-1-(-(2-aminoethoxy)-benzyl -indole in combination with estrogens

Also Published As

Publication number Publication date
HU226587B1 (en) 2009-04-28
AR020074A1 (en) 2002-04-10
BG64783B1 (en) 2006-04-28
EE04262B1 (en) 2004-04-15
SK284666B6 (en) 2005-08-04
FR15C0035I1 (en) 2015-06-26
UA66861C2 (en) 2004-06-15
HRP20000778A2 (en) 2001-06-30
SI1076558T1 (en) 2003-10-31
AU3894499A (en) 1999-12-06
NZ508200A (en) 2003-09-26
LU92699I2 (en) 2015-06-24
JP2009019042A (en) 2009-01-29
TW565554B (en) 2003-12-11
ATE245026T1 (en) 2003-08-15
DE69909616D1 (en) 2003-08-21
PL194750B1 (en) 2007-06-29
PT1076558E (en) 2003-11-28
AP2000001970A0 (en) 2000-12-31
IN192220B (en) 2004-03-20
AP1424A (en) 2005-06-06
HUP0103096A3 (en) 2002-11-28
JP5872624B2 (en) 2016-03-01
GEP20033079B (en) 2003-10-27
WO1999059581A1 (en) 1999-11-25
ES2203131T3 (en) 2004-04-01
KR100620772B1 (en) 2006-09-13
NO2015015I1 (en) 2015-06-02
ID26890A (en) 2001-02-15
EP1076558A1 (en) 2001-02-21
JP2002515431A (en) 2002-05-28
TR200003377T2 (en) 2001-03-21
SK17202000A3 (en) 2001-07-10
EA200001193A1 (en) 2001-12-24
BE2015C026I2 (en) 2018-08-24
CU23241B7 (en) 2007-10-17
HUP0103096A2 (en) 2002-05-29
NO20005770L (en) 2001-01-12
ZA200006959B (en) 2001-11-27
PL345268A1 (en) 2001-12-03
LTC1076558I2 (en) 2016-11-10
FR15C0035I2 (en) 2015-08-28
KR20010043641A (en) 2001-05-25
NO328129B1 (en) 2009-12-14
EP1076558B1 (en) 2003-07-16
IL139130A0 (en) 2001-11-25
DK1076558T3 (en) 2003-11-03
JP2014159472A (en) 2014-09-04
CN1230163C (en) 2005-12-07
IL139130A (en) 2005-11-20
OA11552A (en) 2004-06-07
EE200000652A (en) 2002-04-15
NO20005770D0 (en) 2000-11-14
BR9911040A (en) 2001-02-13
CZ299334B6 (en) 2008-06-25
NO2015015I2 (en) 2015-06-02
HRP20000778B1 (en) 2004-10-31
CA2329530A1 (en) 1999-11-25
EA005932B1 (en) 2005-08-25
HUS1500023I1 (en) 2017-03-28
CN1326347A (en) 2001-12-12
AU760378B2 (en) 2003-05-15
CZ20004254A3 (en) 2001-12-12
DE69909616T2 (en) 2004-06-17
JP5607871B2 (en) 2014-10-15
CY2015020I1 (en) 2020-05-29
BG104930A (en) 2001-07-31

Similar Documents

Publication Publication Date Title
HK1031691A1 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl-indole in combination with estrogens
DE69927412D1 (en) Phosphitadditive in polyolefinen
DE69834346D1 (en) Proteinexpression in baculovirus-vektor expressionsystemen
EP1177136A4 (en) Improvements in containers
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
GB2320435B (en) Improvements in Magnotherapy
GB2345154B (en) Improvements in or relating to positioning
GB2341017B (en) Improvements in lighting
IL143022A0 (en) Improvements in simulators
GB9827986D0 (en) Improvements in hydropyrolysis
GB9805630D0 (en) Improvements in creamic materials
GB9804572D0 (en) Improvements in pipes
GB2335410B (en) Improvements in pouches
GB9804833D0 (en) Improvements in alignment techniques
GB9816215D0 (en) 2 In 1 airjack
GB9617124D0 (en) Improvement in the lavatory
GB9804091D0 (en) Improvements in keyholders
GB9809636D0 (en) Improvements in lamps
GB9706732D0 (en) Improvements in shapemeters
GB9818047D0 (en) Improvements in containers
GB9825567D0 (en) Improvements in text manipulation processes
GB9824416D0 (en) Improvements in barbecue use
GB9914160D0 (en) Improvements in transistors
PL106007U1 (en) Rocking-toy in particular rocking-horse

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20190510